Boston Scientific (BSX) FCF Margin Growth (3y) (2012 - 2026)
Boston Scientific (BSX) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 60.00 |
| 10 | Zimmer Biomet Holdings | 19.23 Bn | 18.82 Bn | 1.54 Bn | 468.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 919.00 |
| Mar 31, 2026 | 96.00 |
| Dec 31, 2025 | 81.00 |
| Sep 30, 2025 | 1,285.00 |
| Jun 30, 2025 | 1,608.00 |
| Mar 31, 2025 | 1,351.00 |
| Dec 31, 2024 | 1,907.00 |
| Sep 30, 2024 | 734.00 |
| Jun 30, 2024 | -148.00 |
| Mar 31, 2024 | -798.00 |
| Dec 31, 2023 | -45.00 |
| Sep 30, 2023 | -794.00 |
| Jun 30, 2023 | 427.00 |
| Mar 31, 2023 | 929.00 |
| Dec 31, 2022 | 93.00 |
| Sep 30, 2022 | -398.00 |
| Jun 30, 2022 | -141.00 |
| Mar 31, 2022 | -1,743.00 |
| Dec 31, 2021 | 1,018.00 |
| Sep 30, 2021 | -555.00 |